Purchase Order N0018317P0933
- Not listed
- This federal contract award, with a ceiling value of $8,000.00, was issued by the Bureau of Medicine and Surgery (part of the Department of Defense) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of surgical implants, with an ultimate completion date of June 26, 2017. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has secured substantial federal contracts with agencies such as the...
- This federal contract award is for a surgical implant provided by Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $5,000.00, was awarded by the Department of the Navy's Bureau of Medicine and Surgery, a Defense agency. The contract is a Firm Fixed Price purchase order with an ultimate completion date of November 8, 2016. The contract does not have a set-aside designation. Arthrex, a for-profit Subchapter S Corporation...
- This federal contract award is for SURGICAL IMPLANTS (2) provided by Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, was awarded this $10,000.00 Firm Fixed Price Purchase Order by the Department of Defense's Bureau of Medicine and Surgery. The contract has no set-aside designation, indicating Arthrex's competitive position in the open market for federal contracts. Arthrex also...
- This federal contract award to Arthrex Inc., a global leader in orthopedic products and procedures, is for the provision of surgical implants. The $5,000.00 firm-fixed-price purchase order was awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery on August 15, 2017, with a completion date of August 16, 2017. The contract does not have a set-aside designation, indicating Arthrex's ability to compete in the open market for federal contracts. Arthrex is an experienced...
- This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, is for the provision of SURGICAL IMPLANTS. The $10,000.00 firm-fixed-price purchase order was awarded on July 10, 2017, by the Bureau of Medicine and Surgery, a Defense agency, with an ultimate completion date of July 24, 2017. The contract does not have a set-aside designation. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has secured...
- This federal contract award, valued at $5,987.50, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of a PROXIMAL TENODESIS IMPLANT SYSTEM, with an ultimate completion date of August 13, 2024. Arthrex, a for-profit Subchapter S Corporation based in Naples, Florida, has secured numerous federal contracts with agencies such as the Department of...
- This federal contract award, valued at $1,113.22, was issued by the Medical Supply Chain division of the Department of Defense (DoD) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of various orthopedic products, including surgical implants, arthroscopic instruments, and biologics. Arthrex is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The contract does not have a set-aside designation,...
- This federal contract award was made by the Defense agency Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $2,722.50 Delivery Order contract has a fixed price with economic price adjustment and an ultimate completion date of August 15, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has secured substantial federal contracts with agencies such as the Department of Veterans Affairs (VA) and...
- This federal contract award, valued at $48,002.70, was issued by the Medical Supply Chain division of the Defense agency to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of the QUADLINK IMPLANT SYSTEM, 11MM, a specialized surgical implant. The contract has a fixed price with economic price adjustment pricing type and a completion date of September 24, 2024. Arthrex is a for-profit Subchapter S Corporation and has received...
- The U.S. government agency Medical Supply Chain has awarded a $2,149.05 fixed-price delivery order contract to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, which has no set-aside designation, is for the delivery of various orthopedic supplies and equipment, including surgical implants, arthroscopic instruments, and biologics. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has secured substantial federal...
This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency within the U.S. government, to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $5,000.00, is for the procurement of a SURGICAL IMPLANT. This is a firm fixed-price purchase order with an ultimate completion date of August 11, 2017. The contract does not have a set-aside designation, indicating Arthrex competed for this award in the open market. Arthrex is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company has secured numerous contracts with government agencies, including the Department of Veterans Affairs (VA) and the Department of Defense (DoD), to provide a wide range of innovative orthopedic technologies, such as surgical implants, arthroscopic instruments, and biologics. This specific contract award is not associated with a larger contract vehicle, but Arthrex holds a significant Indefinite Delivery Contract (IDC) with the VA, valued at $471,048,172.66, that allows VA medical centers nationwide to acquire the company's joint replacement and implant technologies on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 8/12/17 | |
| Not listed | Not listed | $5.0k | 8/8/17 |